DOI: 10.1128/JVI.01374-20
Article Information
PubMed
Published By
History
- Received July 13, 2020
- Accepted October 15, 2020
- Published online December 22, 2020.
Copyright & Usage
Copyright © 2020 American Society for Microbiology. All Rights Reserved.
Editors and / or Reviewers
- Susana López, Editor, Instituto de Biotecnologia/UNAM
Article Versions
- Accepted Manuscript version (October 21, 2020).
- You are viewing the most recent version of this article.
Author Information
- Yuta Kanaia,
- Misa Onishia,
- Takahiro Kawagishia,
- Pimfhun Pannachaa,
- Jeffery A. Nurdina,
- Ryotaro Noudaa,
- Moeko Yamasakia,
- Tina Lusianya,
- Pattara Khamrinb,c,
- Shoko Okitsud,
- Satoshi Hayakawad,
- Hirotaka Ebinae,
- Hiroshi Ushijimad and
- Takeshi Kobayashia
- aDepartment of Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan
- bDepartment of Microbiology, Chiang Mai University, Faculty of Medicine, Chiang Mai, Thailand
- cCenter of Excellence in Emerging and Re-emerging Diarrheal Viruses, Chiang Mai University, Chiang Mai, Thailand
- dDivision of Microbiology, Department of Pathology and Microbiology, Nihon University School of Medicine, Tokyo, Japan
- eBiken Center for Innovative Vaccine Research and Development, The Research Foundation for Microbial Diseases of Osaka University (BIKEN), Suita, Osaka, Japan
- Address correspondence to Takeshi Kobayashi, tkobayashi{at}biken.osaka-u.ac.jp.
Citation Kanai Y, Onishi M, Kawagishi T, Pannacha P, Nurdin JA, Nouda R, Yamasaki M, Lusiany T, Khamrin P, Okitsu S, Hayakawa S, Ebina H, Ushijima H, Kobayashi T. 2021. Reverse genetics approach for developing rotavirus vaccine candidates carrying VP4 and VP7 genes cloned from clinical isolates of human rotavirus. J Virol 95:e01374-20. https://doi.org/10.1128/JVI.01374-20.
